There’s a new weight-loss procedure on the market that’s causing people to lose their lunch—literally. AspireAssist, approved by the Food and Drug Administration (FDA) on Tuesday, is a device that helps people absorb fewer calories by draining one-third of the stomach’s contents after a meal right into the toilet. (Group shudder.)Here’s how it works: Surgeons make a small incision in the abdomen and insert a tube into the stomach using an endoscope. The tube is then connected to a disk-shaped valve that lives outside the body. 20 to 30 minutes after eating, patients rig up a small external device to the valve, open it, and dump the stomach contents into the john. (The device insertion procedure takes about 15 minutes under sedation, and emptying your breakfast frittata into the toilet takes around five to 10 minutes.)See it in action below:RELATED: My Weight Loss Surgery Was a Huge MistakeThe procedure (which is for obese patients age 22 and up) is getting … [Read more...] about The FDA Just Approved a Weight Loss Device that Sucks Food Out of Your Stomach
Fda approves new weight loss drug
After a 13-year dry spell, the Federal Food and Drug Administration (FDA) has approved two new weight-loss pills in less than a month. Are either of these new pills a magic bullet for dieters—or even a helpful weapon to add to their fat-fighting arsenal? The latest FDA-approved pill is called Qsymia, a mix of the appetite-suppressing phentermine (not to be confused with Fenfluramine, a now-illegal ingredient in the infamous weight-loss drug known as fen-phen) and topiramate, an anticonvulsant. While Qsymia was officially approved on Tuesday, this drug combination has been prescribed off-label for years, says Stephen Gullo, Ph.D., president of the Institute for Health and Weight Sciences in New York City. Still, Qsymia, which was formerly known as Qnexa, is meant for a very specific type of patient and could have serious side effects. (Read our take on the first drug, Belviq, here.)How does Qsymia work?Phentermine is a well-known appetite suppressant that’s used for … [Read more...] about Are the New Weight-Loss Pills the Solution?
Wish you could tell your growling belly to shut up? Now there's a drug for that—and it couldn't have come at a better time.weight-loss pill for people who are obese or overweight called lorcacerin, and marketed under the name Belviq. The drug safely turns off the natural signals your body sends to your brain to remind you to eat enough food to maintain your current weight. Sounds swell, right? Here's what you should know before asking your doc for a prescription:Does it really work? And how much weight will I lose? How quickly will the weight come off? Whoa, whoa, whoa. First, the drug is intended to be combined with a reduced-calorie diet and exercise, so it won't just whip you into shape unless you make some changes. While the drug itself will curb hunger, it won't, for instance, keep an emotional eater from downing a tub of ice cream like it's her job, says Holly Herrington, registered dietician at the Center for Lifestyle Medicine at Northwestern Memorial Hospital in … [Read more...] about FDA Approves New Weight-Loss Pill Lorcacerin
The weight loss and obesity issue is rapidly over taking tobacco as the number one health concern for the coming decades. According to Centers for Disease Control and Prevention, more than one-third of adults in the United States are classified as obese. With that in mind, the FDA approved a new appetite suppressant called Belviq (lorcaserin hydrochloride) from Arena Pharmaceuticals. The drug is used for weight management in those who have either high blood pressure, high cholesterol or type 2 diabetes and have a BMI (Body Mass Index) of 27 or greater. A BMI of 27 makes someone overweight, while a BMI of 30 classifies them as obese. It should be used for chronic weight management as an addition to a reduced calorie diet and exercise. Belviq, which is manufactured by the Swiss based company Arena Pharmaceuticals Gmbh., is a slightly different approach to finding the holy grail of weight management. In an approach somewhat similar to the drug Chantex for quitting smoking, it … [Read more...] about FDA Approves New Appetite Suppressant Belviq From Arena Pharmaceuticals
Odomzo works by suppressing the molecular pathway that’s active when the body is inflicted with basal cell cancers. In a clinical study, 66 patients were treated with 200 mg a day of Odomzo, while 128 patients took a daily dose of 800 mg. Researchers found that the drug had the ability to shrink or destroy the cancerous tumor in more than half (58%) of the patients who were taking 200 mg. Furthermore, the effects of the drug lasted anywhere between 1.9 months and one-and-half years—approximately half the patients experienced the effects for at least six months. Similar results were seen in the patients who took the higher dose; however, these individuals also experienced more side effects, which are said to include muscle spasms, distorted sense of taste, hair loss, fatigue, nausea, headaches, abdominal and musculoskeletal pain, vomiting and weight loss, diarrhea, appetite loss, and itching. The FDA also warns that the drug may not be safe for pregnant women, as it can … [Read more...] about FDA Approves New Drug to Treat Common Form of Skin Cancer